These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18958504)

  • 1. Oxidative stress in children on hemodialysis: value of autoantibodies against oxidized low-density lipoprotein.
    Cengiz N; Baskin E; Sezgin N; Agras P; Haberal M
    Pediatr Nephrol; 2009 Feb; 24(2):387-93. PubMed ID: 18958504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between chronic inflammation and cardiovascular risk factors in children on maintenance hemodialysis.
    Cengiz N; Baskin E; Agras PI; Sezgin N; Saatci U
    Transplant Proc; 2005 Sep; 37(7):2915-7. PubMed ID: 16213260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.
    Stenvinkel P; Heimbürger O; Paultre F; Diczfalusy U; Wang T; Berglund L; Jogestrand T
    Kidney Int; 1999 May; 55(5):1899-911. PubMed ID: 10231453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
    Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
    J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy.
    Danielski M; Ikizler TA; McMonagle E; Kane JC; Pupim L; Morrow J; Himmelfarb J
    Am J Kidney Dis; 2003 Aug; 42(2):286-94. PubMed ID: 12900810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis--role of seniority and intravenous ferrotherapy: analysis at 4 years of follow-up.
    Bayés B; Pastor MC; Bonal J; Foraster A; Romero R
    Nephrol Dial Transplant; 2006 Apr; 21(4):984-90. PubMed ID: 16326744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end products and soluble receptor as markers of oxidative stress in children on hemodialysis.
    El-Saeed GS; Fadel F; Elshamaa MF; Galal RE; Elghoroury EA; Nasr SA; Thabet EH; Abdelrahman SM
    Ren Fail; 2015; 37(9):1452-6. PubMed ID: 26337710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-density lipoprotein (LDL)-induced monocyte-endothelial cell adhesion, soluble cell adhesion molecules, and autoantibodies to oxidized-LDL in chronic renal failure patients on dialysis therapy.
    O'Byrne D; Devaraj S; Islam KN; Collazo R; McDonald L; Grundy S; Jialal I
    Metabolism; 2001 Feb; 50(2):207-15. PubMed ID: 11229431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies against oxidized LDL in chronic renal failure: role of renal function, diet, and lipids.
    Bergesio F; Monzani G; Ciuti R; Cirami C; Martinelli F; Salvadori M; Tosi PL
    Nephron; 2001 Feb; 87(2):127-33. PubMed ID: 11244306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study.
    Ikizler TA; Wingard RL; Harvell J; Shyr Y; Hakim RM
    Kidney Int; 1999 May; 55(5):1945-51. PubMed ID: 10231458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients.
    Shoji T; Kimoto E; Shinohara K; Emoto M; Ishimura E; Miki T; Tsujimoto Y; Tabata T; Nishizawa Y
    Kidney Int Suppl; 2003 May; (84):S128-30. PubMed ID: 12694327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of anti-apolipoprotein/A-1 autoantibodies in maintenance hemodialysis and association with dialysis vintage.
    Pruijm M; Schmidtko J; Aho A; Pagano S; Roux-Lombard P; Teta D; Burnier M; Vuilleumier N
    Ther Apher Dial; 2012 Dec; 16(6):588-94. PubMed ID: 23190520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Main determinants of PON1 activity in hemodialysis patients.
    Ribeiro S; do Sameiro Faria M; Mascarenhas-Melo F; Freitas I; Mendonça MI; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Belo L; Costa E; Reis F; Santos-Silva A
    Am J Nephrol; 2012; 36(4):317-23. PubMed ID: 23007074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.
    Vaziri ND; Navab K; Gollapudi P; Moradi H; Pahl MV; Barton CH; Fogelman AM; Navab M
    J Natl Med Assoc; 2011 Jun; 103(6):524-33. PubMed ID: 21830637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress influences CC-chemokine levels in hemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Nephron Physiol; 2004; 96(4):p105-12. PubMed ID: 15122056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive association between plasma levels of oxidized low-density lipoprotein and myeloperoxidase after hemodialysis in patients with diabetic end-stage renal disease.
    Kitabayashi C; Naruko T; Sugioka K; Yunoki K; Nakagawa M; Inaba M; Ohsawa M; Konishi Y; Imanishi M; Inoue T; Itabe H; Yoshiyama M; Haze K; Becker AE; Ueda M
    Hemodial Int; 2013 Oct; 17(4):557-67. PubMed ID: 23627905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.